Progression of Conventional Cardiovascular Risk Factors and Vascular Disease Risk in Individuals: Insights from the PROG-IMT Consortium

Aims: Averaged measurements, but not the progression based on multiple assessments of carotid intima-media thickness, (cIMT) are predictive of cardiovascular disease (CVD) events in individuals. Whether this is true for conventional risk factors is unclear.

Methods And Results: An individual participant meta-analysis was used to associate the annualised progression of systolic blood pressure, total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with future cardiovascular disease risk in 13 prospective cohort studies of the PROG-IMT collaboration ( = 34,072). Follow-up data included information on a combined cardiovascular disease endpoint of myocardial infarction, stroke, or vascular death. In secondary analyses, annualised progression was replaced with average. Log hazard ratios per standard deviation difference were pooled across studies by a random effects meta-analysis. In primary analysis, the annualised progression of total cholesterol was marginally related to a higher cardiovascular disease risk (hazard ratio (HR) 1.04, 95% confidence interval (CI) 1.00 to 1.07). The annualised progression of systolic blood pressure, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol was not associated with future cardiovascular disease risk. In secondary analysis, average systolic blood pressure (HR 1.20 95% CI 1.11 to 1.29) and low-density lipoprotein cholesterol (HR 1.09, 95% CI 1.02 to 1.16) were related to a greater, while high-density lipoprotein cholesterol (HR 0.92, 95% CI 0.88 to 0.97) was related to a lower risk of future cardiovascular disease events.

Conclusion: Averaged measurements of systolic blood pressure, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol displayed significant linear relationships with the risk of future cardiovascular disease events. However, there was no clear association between the annualised progression of these conventional risk factors in individuals with the risk of future clinical endpoints.

Citing Articles

Neurovascular disease in Switzerland: 10-year trends show non-traditional risk factors on the rise and higher exposure in women.

Hansel M, Steigmiller K, Luft A, Gebhard C, Held U, Wegener S Eur J Neurol. 2022; 29(9):2851-2860.

PMID: 35661347 PMC: 9541902. DOI: 10.1111/ene.15434.

Off-Target Effects of Antidepressants on Vascular Function and Structure.

Dimoula A, Fotellis D, Aivalioti E, Delialis D, Polissidis A, Patras R Biomedicines. 2022; 10(1).

PMID: 35052735 PMC: 8773150. DOI: 10.3390/biomedicines10010056.

Mild Head Trauma: Is Antiplatelet Therapy a Risk Factor for Hemorrhagic Complications?.

Savioli G, Ceresa I, Luzzi S, Lucifero A, Pioli Di Marco M, Manzoni F Medicina (Kaunas). 2021; 57(4).

PMID: 33917141 PMC: 8067857. DOI: 10.3390/medicina57040357.

Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failure.

Gencer B, Bonomi M, Adorni M, Sirtori C, Mach F, Ruscica M Rev Endocr Metab Disord. 2021; 22(2):257-274.

PMID: 33616800 PMC: 8087565. DOI: 10.1007/s11154-021-09628-2.

References

Tervahauta M, Pekkanen J, Enlund H, Nissinen A . Change in blood pressure and 5-year risk of coronary heart disease among elderly men: the Finnish cohorts of the Seven Countries Study. J Hypertens. 1994; 12(10):1183-9. View

Wallenfeldt K, Bokemark L, Wikstrand J, Hulthe J, Fagerberg B . Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke. 2004; 35(10):2248-52. DOI: 10.1161/01.STR.0000140629.65145.3c. View

Laitinen D, Manthena S . Impact of change in high-density lipoprotein cholesterol from baseline on risk for major cardiovascular events. Adv Ther. 2010; 27(4):233-44. DOI: 10.1007/s12325-010-0019-4. View

Paige E, Barrett J, Pennells L, Sweeting M, Willeit P, Di Angelantonio E . Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis. Am J Epidemiol. 2017; 186(8):899-907. PMC: 5860526. DOI: 10.1093/aje/kwx149. View

Iglesias Del Sol A, Bots M, Grobbee D, Hofman A, Witteman J . Carotid intima-media thickness at different sites: relation to incident myocardial infarction; The Rotterdam Study. Eur Heart J. 2002; 23(12):934-40. DOI: 10.1053/euhj.2001.2965. View

Benjamin E, Virani S, Callaway C, Chamberlain A, Chang A, Cheng S . Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018; 137(12):e67-e492. DOI: 10.1161/CIR.0000000000000558. View

Lorenz M, Polak J, Kavousi M, Mathiesen E, Volzke H, Tuomainen T . Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet. 2012; 379(9831):2053-62. PMC: 3918517. DOI: 10.1016/S0140-6736(12)60441-3. View

Leng G, Lee A, Fowkes F, Whiteman M, Dunbar J, Housley E . Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996; 25(6):1172-81. DOI: 10.1093/ije/25.6.1172. View

Sesso H, Stampfer M, Rosner B, Hennekens C, Gaziano J, Manson J . Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertension. 2000; 36(5):801-7. DOI: 10.1161/01.hyp.36.5.801. View

10.

Timmis A, Townsend N, Gale C, Grobbee R, Maniadakis N, Flather M . European Society of Cardiology: Cardiovascular Disease Statistics 2017. Eur Heart J. 2017; 39(7):508-579. DOI: 10.1093/eurheartj/ehx628. View

11.

van Sloten T, Tafflet M, Perier M, Dugravot A, Climie R, Singh-Manoux A . Association of Change in Cardiovascular Risk Factors With Incident Cardiovascular Events. JAMA. 2018; 320(17):1793-1804. PMC: 6248104. DOI: 10.1001/jama.2018.16975. View

12.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

13.

Glymour M, Weuve J, Berkman L, Kawachi I, Robins J . When is baseline adjustment useful in analyses of change? An example with education and cognitive change. Am J Epidemiol. 2005; 162(3):267-78. DOI: 10.1093/aje/kwi187. View

14.

Borghi C, Dormi A, LItalien G, Lapuerta P, Franklin S, Collatina S . The relationship between systolic blood pressure and cardiovascular risk--results of the Brisighella Heart Study. J Clin Hypertens (Greenwich). 2003; 5(1):47-52. PMC: 8101870. DOI: 10.1111/j.1524-6175.2003.01222.x. View

15.

Benetos A, Zureik M, Morcet J, Thomas F, Bean K, Safar M . A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol. 2000; 35(3):673-80. DOI: 10.1016/s0735-1097(99)00586-0. View

16.

Menotti A, Blackburn H, Kromhout D, Nissinen A, Fidanza F, Giampaoli S . Changes in population cholesterol levels and coronary heart disease deaths in seven countries. Eur Heart J. 1997; 18(4):566-71. DOI: 10.1093/oxfordjournals.eurheartj.a015298. View

17.

Sander D, Kukla C, Klingelhofer J, Winbeck K, Conrad B . Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study. Circulation. 2000; 102(13):1536-41. DOI: 10.1161/01.cir.102.13.1536. View

18.

Lorenz M, Markus H, Bots M, Rosvall M, Sitzer M . Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007; 115(4):459-67. DOI: 10.1161/CIRCULATIONAHA.106.628875. View

19.

Barnett A, van der Pols J, Dobson A . Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2004; 34(1):215-20. DOI: 10.1093/ije/dyh299. View

20.

Iribarren C, Reed D, Chen R, Yano K, Dwyer J . Low serum cholesterol and mortality. Which is the cause and which is the effect?. Circulation. 1995; 92(9):2396-403. DOI: 10.1161/01.cir.92.9.2396. View